title: Telomerase activity in benign and malignant adrenal tumors.
abstract: Histological analysis of surgically removed adrenal masses often fails to differentiate between benign and malignant tumors. In normal cells, the telomeric ends of the chromosomes are shortened with each cell division, leading to chromosome destabilization and cellular senescence after a critical number of cell cycles. In tumor cells, telomere shortening is prevented by a specific DNA polymerase, called telomerase. In an effort to clarify the role of telomerase in the pathogenesis of adrenal tumors, and to test whether its activity could serve as marker of malignancy, we measured telomerase activity in 41 human adrenal tissue samples that were classified both by the clinical course and by histological examination. Telomerase activity was determined by TRAP ELISA and expressed as high (>50% of positive control telomerase activity), medium (31-50%), low (11-30%), very low (< or = 10%), or absent (0%). The 8 normal adrenal tissue samples showed very low levels of telomerase activity. Mean telomerase activity also very low in 3/3 incidentalomas, 6/6 Cushing adenomas, 6/6 Conn adenomas, 7/7 adrenocortical carcinomas, 8/8 benign pheochromocytomas, and 2/3 malignant pheochromocytomas. In contrast, one malignant pheochromocytoma showed high telomerase activity. These data indicate that telomerase activity may not be a suitable marker for malignancy in the adrenal gland. Our results also challenge the current dogma of close correlation between cell dedifferentiation and telomerase activity.
authors.affiliation: IHF Institute for Hormone and Fertility Research, University of Hamburg, Germany. bamberger@plexus.uke.uni-hamburg.de
authors.forename: C M
authors.initials: CM
authors.lastname: Bamberger
authors.forename: T
authors.initials: T
authors.lastname: Else
authors.forename: A M
authors.initials: AM
authors.lastname: Bamberger
authors.forename: A
authors.initials: A
authors.lastname: Frilling
authors.forename: F U
authors.initials: FU
authors.lastname: Beil
authors.forename: B
authors.initials: B
authors.lastname: Allolio
authors.forename: H M
authors.initials: HM
authors.lastname: Schulte
mesh_terms: D000236:Adenoma / Q000201:enzymology / Q000503:physiopathology; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000201:enzymology*; D000311:Adrenal Glands / Q000201:enzymology* / Q000503:physiopathology; D018268:Adrenocortical Carcinoma / Q000201:enzymology / Q000503:physiopathology; D001560:Benzidines / Q000737:chemistry; D014408:Biomarkers, Tumor; D002863:Chromogenic Compounds / Q000737:chemistry; D006651:Histocytochemistry; D006801:Humans; D019169:Jurkat Cells; D009693:Nucleic Acid Hybridization; D010673:Pheochromocytoma / Q000201:enzymology / Q000503:physiopathology; D016133:Polymerase Chain Reaction; D019098:Telomerase / Q000032:analysis / Q000502:physiology*
chemical_list: D001560:Benzidines; D014408:Biomarkers, Tumor; D002863:Chromogenic Compounds; C021758:3,3',5,5'-tetramethylbenzidine; D019098:Telomerase